According to Evolent Health's latest financial reports the company has $0.14 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.18 B | -29.32% |
2021-12-31 | $0.26 B | -21.8% |
2020-12-31 | $0.34 B | 237.09% |
2019-12-31 | $0.10 B | -55.76% |
2018-12-31 | $0.22 B | -4.24% |
2017-12-31 | $0.23 B | 33.27% |
2016-12-31 | $0.17 B | 15.29% |
2015-12-31 | $0.15 B | |
2014-12-31 | $N/A | -100% |
2013-12-31 | $67.89 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() National Healthcare
NHC | $0.19 B | 35.72% | ๐บ๐ธ USA |
![]() Global Cord Blood CORBF | $1.04 B | 636.41% | ๐ญ๐ฐ Hong Kong |
![]() Graham Holdings GHC | $0.77 B | 442.37% | ๐บ๐ธ USA |
![]() CryoLife CRY | N/A | N/A | ๐บ๐ธ USA |